Kenneth Galbraith - Net Worth and Insider Trading
Kenneth Galbraith Net Worth
The estimated net worth of Kenneth Galbraith is at least $334,807 dollars as of 2024-12-01. Kenneth Galbraith is the Chair & CEO of Zymeworks Inc and owns about 23,762 shares of Zymeworks Inc (ZYME) stock worth over $334,807. Kenneth Galbraith is also the Director of Macrogenics Inc and owns about 0 shares of Macrogenics Inc (MGNX) stock worth over $0. Details can be seen in Kenneth Galbraith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth Galbraith has not made any transactions after 2024-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth Galbraith
Kenneth Galbraith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth Galbraith owns 3 companies in total, including Macrogenics Inc (MGNX) , Celator Pharmaceuticals Inc (CPXX) , and Zymeworks Inc (ZYME) .
Click here to see the complete history of Kenneth Galbraith’s form 4 insider trades.
Insider Ownership Summary of Kenneth Galbraith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MGNX | Macrogenics Inc | 2020-09-09 | director |
| CPXX | Celator Pharmaceuticals Inc | 2013-06-03 | director |
| ZYME | Zymeworks Inc | 2024-01-08 | director & Chair & CEO |
Kenneth Galbraith Latest Holdings Summary
Kenneth Galbraith currently owns a total of 2 stocks. Among these stocks, Kenneth Galbraith owns 23,762 shares of Zymeworks Inc (ZYME) as of January 8, 2024, with a value of $334,807 and a weighting of 100%. Kenneth Galbraith also owns 0 shares of Macrogenics Inc (MGNX) as of September 9, 2020, with a value of $0 and a weighting of 0%.
Latest Holdings of Kenneth Galbraith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZYME | Zymeworks Inc | 2024-01-08 | 23,762 | 14.09 | 334,807 |
| MGNX | Macrogenics Inc | 2020-09-09 | 0 | 3.59 | 0 |
Holding Weightings of Kenneth Galbraith
Kenneth Galbraith Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth Galbraith has made a total of 1 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zymeworks Inc is the sale of 23,904 shares on January 8, 2024, which brought Kenneth Galbraith around $257,924.
According to the SEC Form 4 filings, Kenneth Galbraith has made a total of 1 transactions in Macrogenics Inc (MGNX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Macrogenics Inc is the sale of 20,773 shares on September 9, 2020, which brought Kenneth Galbraith around $563,156.
Insider Trading History of Kenneth Galbraith
- 1
Kenneth Galbraith Trading Performance
GuruFocus tracks the stock performance after each of Kenneth Galbraith's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth Galbraith is 52.06%. GuruFocus also compares Kenneth Galbraith's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth Galbraith within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kenneth Galbraith's insider trading performs compared to the benchmark.
Performance of Kenneth Galbraith
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.61 | | | | | |
| Relative Return to S&P 500(%) | 2.16 | | | | | |
Kenneth Galbraith Ownership Network
Kenneth Galbraith Owned Company Details
What does Macrogenics Inc do?
Who are the key executives at Macrogenics Inc?
Kenneth Galbraith is the director of Macrogenics Inc. Other key executives at Macrogenics Inc include Acting General Counsel Jeffrey Stuart Peters , SVP & CFO and Secretary James Karrels , and Sr VP & BPD & Manufacturing Thomas Spitznagel .
Macrogenics Inc (MGNX) Insider Trades Summary
Over the past 18 months, Kenneth Galbraith made no insider transaction in Macrogenics Inc (MGNX). Other recent insider transactions involving Macrogenics Inc (MGNX) include a net sale of 163,395 shares made by Jeffrey Stuart Peters , a net sale of 48,846 shares made by Ezio Bonvini , and a net purchase of 350,000 shares made by Biotech Target N V .
In summary, during the past 3 months, insiders sold 0 shares of Macrogenics Inc (MGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 293,400 shares of Macrogenics Inc (MGNX) were sold and 365,000 shares were bought by its insiders, resulting in a net purchase of 71,600 shares.
Macrogenics Inc (MGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Macrogenics Inc Insider Transactions
Kenneth Galbraith Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth Galbraith. You might contact Kenneth Galbraith via mailing address: Ocean Park Rpo Po Box 45025, 12851 16th Ave, Surrey A1 V4a9l1.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
